Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 18/20 | 0.69 |
| ▸ | HSP90AB1 | P08238 | 9/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.39 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2078001 | 0.91 | HSP90AA1 (0.71) | HSP90AA1HSP90AB1KMT2APDK1PDK2 | |
| SCHEMBL1219124 | 0.91 | HSP90AA1 (0.71) | HSP90AA1HSP90AB1KMT2A | |
| SCHEMBL2080906 | 0.91 | HSP90AA1 (0.76) | HSP90AA1HSP90AB1KMT2APDK1PDK2 | |
| SCHEMBL2080084 | 0.89 | HSP90AA1 (0.69) | HSP90AA1HSP90AB1 | |
| SCHEMBL2078891 | 0.89 | HSP90AA1 (0.69) | HSP90AA1HSP90AB1 | |
| SCHEMBL2079326 | 0.88 | HSP90AA1 (0.67) | HSP90AA1HSP90AB1PDK1 | |
| SCHEMBL2077553 | 0.87 | HSP90AA1 (0.74) | HSP90AA1HSP90AB1KMT2A | |
| SCHEMBL2080398 | 0.87 | HSP90AA1 (0.74) | HSP90AA1HSP90AB1KMT2A | |
| SCHEMBL2079392 | 0.87 | HSP90AA1 (0.66) | HSP90AA1HSP90AB1PDK1 | |
| SCHEMBL2080377 | 0.86 | HSP90AA1 (0.70) | HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2018370-B1 | 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS | MERCK PATENT GMBH (DE) | 2013-03-27 | — | — | EP | claimed |
| US-7906657-B2 | 1,5-diphenylpyrazoles II as HSP90 inhibitors | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2011-03-15 | — | — | US | claimed |
| US-20090325974-A1 | 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS | MERCK PATENT GESELLSCHAFT (DE) | 2009-12-31 | — | — | US | claimed |
| EP-2018370-B1 | 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS | MERCK PATENT GMBH (DE) | 2013-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325974-A1 | 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS | HSP90AB1, HSP90AA1, HSP90AB2P | HSP90AA1 2/4885HSP90AB1 1/4885KMT2A 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.